The COSMIQ Blog

Articles tagged “ash 2026” · Clear filter

Exam Prep

Early SynKIR-310 Data Put Safety Questions at Center of ASH Talk

Verismo Therapeutics says its first-in-human SynKIR-310 study reported responses in a small early-phase cohort without reported CRS or ICANS at the first two dose levels. The December ASH presentation is expected to add data from a third cohort.

By Dr. Matthew Lynch · November 5, 2026 · 5 min read

Learn anything, free.

COSMIQ is a free, voice-driven AI tutor for every learner. No credit card, ever.

Start learning free →